These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31873975)

  • 1. Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
    Holper L
    Res Synth Methods; 2020 Mar; 11(2):275-286. PubMed ID: 31873975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
    Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
    Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
    Rao Y; Yang R; Zhao J; Cao Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):480-490. PubMed ID: 37202104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials.
    Holper L; Hengartner MP
    BMC Psychiatry; 2020 Sep; 20(1):437. PubMed ID: 32894088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: A network meta-analysis.
    Li X; Zhang C
    J Affect Disord; 2020 Apr; 266():540-548. PubMed ID: 32056924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
    Noma H; Furukawa TA; Maruo K; Imai H; Shinohara K; Tanaka S; Ikeda K; Yamawaki S; Cipriani A
    J Affect Disord; 2019 May; 250():419-424. PubMed ID: 30878654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Antidepressants in Combination with Psychotherapy.
    Alemi F; Soylu TG; Cannon M; McCandless C
    J Ment Health Policy Econ; 2024 Mar; 27(1):3-12. PubMed ID: 38634393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
    Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
    CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
    JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal doses of antidepressants in dependence on age: Combined covariate actions in Bayesian network meta-analysis.
    Holper L
    EClinicalMedicine; 2020 Jan; 18():100219. PubMed ID: 31993575
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.
    Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A
    BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
    Di Nicola M; Dell'Osso B; Peduto I; Cipelli R; Pugliese AC; Signorelli MS; Ventriglio A; Martinotti G
    Curr Neuropharmacol; 2023; 21(3):727-739. PubMed ID: 35410606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.
    Shinohara K; Efthimiou O; Ostinelli EG; Tomlinson A; Geddes JR; Nierenberg AA; Ruhe HG; Furukawa TA; Cipriani A
    BMJ Open; 2019 May; 9(5):e027574. PubMed ID: 31110100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
    Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
    Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
    Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
    Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.